Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Shalini Sood-Mendiratta"'
Autor:
Richard Quinones, Levi N. Kanu, Deepak P. Edward, Anjali S Hawkins, Kiran Malhotra, Thasarat S. Vajaranant, Richard A Lehrer, Robert Papas, Jacob T. Wilensky, Ahmad A. Aref, Shalini Sood-Mendiratta, Amy A. Mehta, David Hillman
Publikováno v:
European Journal of Ophthalmology. 32:322-326
Purpose: To assess the effectiveness and safety of adjunctive topical netarsudil 0.02% and latanoprostene bunod 0.024% in patients with glaucoma. Methods: A retrospective, multi-center, cohort study of patients with glaucoma treated with netarsudil 0
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1275fb5a4056afca60e87691de1c8bf9
https://doi.org/10.1177/1120672121998913
https://doi.org/10.1177/1120672121998913
Autor:
Edward J. Rockwood, Jonathan E. Sears, Annapurna Singh, Fabiana Q. Silva, Mona Kaleem, Jonathan Eisengart, Vivian L. Qin, Shalini Sood-Mendiratta, Felipe F Conti, Rishi P Singh
Publikováno v:
Journal of Glaucoma. 27:440-444
To compare long-term surgical outcomes and complications of pars plana (PP) tube implantation with conventional anterior chamber (AC) tube implantation.Records of patients undergoing glaucoma tube implant surgery at a single institution between 2007
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9732f8328301c59863c85f8f4acd4db2
https://doi.org/10.1097/ijg.0000000000000931
https://doi.org/10.1097/ijg.0000000000000931
Autor:
Shalini Sood-Mendiratta
Publikováno v:
Glaucoma
When evaluating patients for glaucoma or ocular hypertension, the question remains whether or not the patient should be treated, and when treatment should be initiated. Treatment decisions are usually guided by risk factor assessment, and these inclu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::76a7641d71ccf5eabfabfd365bea74e0
https://doi.org/10.1093/oso/9780199757084.003.0015
https://doi.org/10.1093/oso/9780199757084.003.0015
